CD177 and cancer: Curcumin also has abilities to induce cell apoptosis, suppress the expression of multiple oncogenes and transcription factors inducing epithelial-to-mesenchymal transition (EMT) in cancer cells through interfering with the binding of Wnt to its cell surface receptor in the Wnt/β-catenin signaling pathway, suggesting curcumin as a potential target for anticancer therapies [60].